Dopaminergic activity and the discriminative stimulus effects of mu opioids in pigeons:: importance of training dose and attenuation by the D3 agonist (±)-7-OH-DPAT

被引:14
作者
Cook, CD [1 ]
Picker, MJ [1 ]
机构
[1] Univ N Carolina, Dept Psychol, Chapel Hill, NC 27599 USA
关键词
drug discrimination; butorphanol; opioids; dopamine; (+/-)-7-OH-DPAT; pigeons;
D O I
10.1007/s002130050539
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The present investigation examined the effects of several dopaminergic compounds in pigeons trained to discriminate either a 0.1 (low) or 5.6 (high) mg/kg dose of the mu opioid butorphanol from saline. Various dopamine (DA) re-uptake inhibitors, releasers, a D-1 agonist, a D-2 agonist and a D-3 agonist engendered partial substitution (50-79% butorphanol responding) for the butorphanol stimulus in the low-dose group. In the high-dose group, with a few exceptions, these compounds produced predominately saline responding. In the low-dose group, the opioid antagonist naloxone antagonized the stimulus effects produced by butorphanol, but failed to attenuate the butorphanol-like discriminative stimulus effects produced by the DA re-uptake inhibitors mazindol and cocaine. The D-1 antagonist (+)-SCH 23390 and the D-2 antagonist raclopride failed to attenuate the stimulus effects produced by either the low or high training dose of butorphanol. Doses of mazindol and cocaine that engendered between 16% and 70% butorphanol responding failed to alter the butorphanol dose-effect curve in either the low-or high-dose group, indicating a less than additive interaction. In the high-dose group, the D-3 agonist (+/-)-7-hydroxy-dipropylaminotetralin [(+/-)-7-OH-DPAT] attenuated butorphanol's stimulus effects in a dose-dependent manner along with the butorphanol-like stimulus effects produced by nalbuphine and morphine. The present ent findings indicate that direct and indirect DA agonists share similar stimulus effects with a low but not high training dose of butorphanol, and in the high-training dose group, activation of the D-3 receptor by (+/-)-7-OH-DPAT results in the attenuation of the discriminative stimulus effects of mu opioids.
引用
收藏
页码:59 / 69
页数:11
相关论文
共 54 条
[1]   SCH 23390 BLOCKS DRUG-CONDITIONED PLACE-PREFERENCE AND PLACE-AVERSION - ANHEDONIA (LACK OF REWARD) OR APATHY (LACK OF MOTIVATION) AFTER DOPAMINE-RECEPTOR BLOCKADE [J].
ACQUAS, E ;
CARBONI, E ;
LEONE, P ;
DICHIARA, G .
PSYCHOPHARMACOLOGY, 1989, 99 (02) :151-155
[2]  
BAKER LE, 1993, BEHAV PHARMACOL, V4, P69
[3]   ASSESSMENT OF THE DISCRIMINATIVE STIMULUS EFFECTS OF COCAINE IN THE RAT - LACK OF INTERACTION WITH OPIOIDS [J].
BROADBENT, J ;
GASPARD, TM ;
DWORKIN, SI .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1995, 51 (2-3) :379-385
[4]   DOPAMINE-D1 AND DOPAMINE-D2 MEDIATION OF THE DISCRIMINATIVE STIMULUS PROPERTIES OF D-AMPHETAMINE AND COCAINE [J].
CALLAHAN, PM ;
APPEL, JB ;
CUNNINGHAM, KA .
PSYCHOPHARMACOLOGY, 1991, 103 (01) :50-55
[5]   FACTORS REGULATING DRUG CUE SENSITIVITY - THE EFFECT OF TRAINING DOSE IN FENTANYL-SALINE DISCRIMINATION [J].
COLPAERT, FC ;
NIEMEGEERS, CJE ;
JANSSEN, PAJ .
NEUROPHARMACOLOGY, 1980, 19 (08) :705-713
[6]   FENTANYL AND APOMORPHINE - ASYMMETRICAL GENERALIZATION OF DISCRIMINATIVE STIMULUS PROPERTIES [J].
COLPAERT, FC ;
NIEMEGEERS, CJE ;
JANSSEN, PAJ .
NEUROPHARMACOLOGY, 1976, 15 (09) :541-545
[7]   DISCRIMINATIVE STIMULUS PROPERTIES OF COCAINE - NEURO-PHARMACOLOGICAL CHARACTERISTICS AS DERIVED FROM STIMULUS-GENERALIZATION EXPERIMENTS [J].
COLPAERT, FC ;
NIEMEGEERS, CJE ;
JANSSEN, PAJ .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1979, 10 (04) :535-546
[8]  
COOK CD, 1997, IN PRESS SOC NEUROSC
[9]   SELECTIVE D1-DOPAMINE AND D2-DOPAMINE ANTAGONISTS DECREASE RESPONSE RATES OF FOOD-MAINTAINED BEHAVIOR AND REDUCE THE DISCRIMINATIVE STIMULUS PRODUCED BY HEROIN [J].
CORRIGALL, WA ;
COEN, KM .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 35 (02) :351-355
[10]   THE DOPAMINE-RECEPTOR AGONIST 7-OH-DPAT MODULATES THE ACQUISITION AND EXPRESSION OF MORPHINE-INDUCED PLACE PREFERENCE [J].
DEFONSECA, FR ;
RUBIO, P ;
MARTINCALDERON, JL ;
CAINE, SB ;
KOOB, GF ;
NAVARRO, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 274 (1-3) :47-55